TRxADE HEALTH, Inc. (MEDS) Financials
MEDS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 14.8 million | 3.1 million |
| March 31, 2024 | 16.7 million | 3.1 million |
| Dec. 31, 2023 | 12.5 million | 12.0 million |
| Sept. 30, 2023 | 21.7 million | 10.1 million |
MEDS Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | 4.2 million | ? |
| March 31, 2024 | -10.2 million | 4.5 million |
| Dec. 31, 2023 | -728649 | 178473 |
| Sept. 30, 2023 | -603112 | 3760 |
MEDS Net Income
No data available :(
MEDS Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 7.7 million | 160996 | 160996 |
| March 31, 2024 | 3.5 million | 168976 | 168976 |
| Dec. 31, 2023 | 151908 | 434205 | 548910 |
| Sept. 30, 2023 | 34031 | 1.0 million | 1.2 million |
MEDS Shares Outstanding
MEDS Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | - | 86674 | 1.5 million | 570431 |
| March 31, 2024 | 138875 | 53859 | 5.5 million | 607775 |
| Dec. 31, 2023 | 138875 | 366534 | 3.6 million | - |
| Sept. 30, 2023 | - | 410612 | 2.1 million | - |
MEDS Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 18699 | 19402 |
| March 31, 2024 | 2.4 million | 8303 |
| Dec. 31, 2023 | 2.4 million | 4.6 million |
| Sept. 30, 2023 | 2.1 million | 353450 |
MEDS Revenue by Segment
MEDS
Price: $7.59
Forward Dividend Yield: 105.40%
Payout Ratio: -32.81%
Dividend Per Share: 8.00 USD
Earnings Per Share: -24.38 USD
Exchange: NCM
Sector: Healthcare
Industry: Pharmaceutical Retailers
Country: United States
Volume: 396410
Market Capitalization: 12.8 million
Average Dividend Frequency: 1
Years Paying Dividends: 1